News for Precipio, Inc. (PRPO)

Precipio (PRPO) restructures its warrant agreement to exercise 100,000 warrants for cash and 200,000 warrants cashlessly. The restructuring reduces pote

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from

AAPL, ORCL, and GS stand out with cloud strength, AI-driven growth, and investment banking momentum despite macro headwinds.

Precipio (PRPO) urges shareholders to vote by June 16, 2025, to meet the quorum for the upcoming Annual Shareholders Meeting. Only 42% of shares have been v

**media[656347]**

Discover how Precipio's Q1 2025 performance highlights 43% revenue growth, margin expansion, and key regulatory wins.

Precipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ETCompany ParticipantsIlan Danieli - Chief Executive OfficerConference...

On May 15, 2025, Precipio Inc (PRPO) released its 8-K filing detailing its financial results for the first quarter of 2025. Precipio Inc, a healthcare solutions

**media[626289,626290]**

Precipio, Inc. (PRPO), a leader in cancer diagnostics, will host its Q1-2025 shareholder update call on May 15th, 2025. The conference call will tak

Shares of Coursera, Inc. COUR rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Cours...

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) and The Progressive Corporation (PGR), as well as two micro-cap stocks The Monarch Cement Company (MCEM) and Precipio, Inc. (PRPO).

Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ETCompany ParticipantsIlan Danieli - Chief Executive OfficerConference...

Conference Call to be held on March 31st, 2025 at 5:00 PM ESTNEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipi

**media[568957]**

Both metrics demonstrate the ability to achieve financial independence NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics comp

**media[517412]**

Visa, AbbVie, Analog Devices and Precipio are included in this Analyst Blog.

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI), as well as a micro-cap stock Precipio, Inc. (PRPO).